arrow
M

M. Beylot-Barry

bordeaux institute of oncology
H指数:65
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Durable remission with no survival reduction after mogamulizumab discontinuation in Sézary syndrome

在Sézary综合征中,停止使用mogamulizumab后可获得持久的缓解且不影响生存

2026-07-230
PRE
LY08 Real-world outcomes and survival with targeted and established systemic therapies in advanced-stage cutaneous T-cell lymphoma: an updated PROCLIPI analysis

LY08 晚期皮肤T细胞淋巴瘤靶向治疗与标准系统性治疗的实际疗效及生存结局:PROCLIPI研究的更新分析

2026-06-260
OAAI
Head and neck manifestations associated with hidradenitis suppurativa: A retrospective multicentre study

hidradenitis suppurativa相关的头颈部表现:一项回顾性多中心研究

2026-05-080
PRE
Cutaneous diffuse large B-cell lymphoma induces a macrophage immunosuppressive phenotype through IL-10 secretion.

皮肤弥漫大B细胞淋巴瘤通过分泌IL-10诱导巨噬细胞免疫抑制表型。

2025-12-080
OAAI
European Organisation for Research and Treatment of Cancer, United States Cutaneous Lymphoma Consortium and International Society for Cutaneous Lymphomas consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders

欧洲癌症研究与治疗组织、美国皮肤淋巴瘤联盟和国际皮肤淋巴瘤学会关于皮肤淋巴增生性疾病的诊疗共识建议

2025-10-011
OAAI
Impact of methotrexate administration route on drug survival in psoriasis: Results from PSOBIOTEQ

甲氨蝶呤给药途径对银屑病患者药物生存期的影响:PSOBIOTEQ研究的结果

2025-09-010
PRE
Genomic and clinical characterization of anogenital basal cell carcinoma: A retrospective and prospective cohort study

肛生殖器基底细胞癌的基因组与临床特征:一项回顾性与前瞻性队列研究

2025-08-230
PRE
Metabolism-based scoring of cutaneous squamous cell carcinoma to predict tumour features and responses to treatment with dihydroorotate dehydrogenase inhibitors

基于代谢的皮肤鳞状细胞癌评分以预测肿瘤特征及对二氢乳清酸脱氢酶抑制剂的反应

2025-08-010
OAAI
A multicentre pragmatic randomized controlled trial comparing 50% salicylic acid, liquid nitrogen, 5% 5-fluorouracil cream, and 5% imiquimod cream in previously treated plantar warts. The VRAIE (VeRrues plAntaIres en villE) study

一项多中心实用型随机对照试验,比较50%水杨酸、液氮、5% 5-氟尿嘧啶乳膏和5%咪喹莫特乳膏在既往治疗过的跖疣中的应用。VRAIE(VeRrues plAntaIres en villE)研究

2025-07-300
OAAI
A New Prognostic Index (CLIPI) for Advanced Cutaneous Lymphoma Enables Precise Patient Risk Stratification

一个新的预后指数(CLIPI)用于晚期皮肤淋巴瘤,可实现精确的患者风险分层

Blood
IF23.1
2025-07-170
PRE
Long-Term Efficacy and Safety of Rituximab in Patients With Pemphigus Foliaceus Compared With Pemphigus Vulgaris

利妥昔单抗在落叶型天疱疮患者中的长期疗效与安全性,并与寻常型天疱疮进行比较

2025-04-010
PRE